Regonol

Regonol is a brand name of pyridostigmine, approved by the FDA in the following formulation(s):

REGONOL (pyridostigmine bromide - injectable; injection)

• 
  Manufacturer: SANDOZ
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 5MG/ML ^[AP]

Has a generic version of Regonol been approved?

No. There is currently no therapeutically equivalent version of Regonol available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Regonol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Regonol.

See also...

• Regonol Consumer Information (Wolters Kluwer)
• Pyridostigmine Consumer Information (Wolters Kluwer)
• Pyridostigmine Controlled-Release Tablets Consumer Information (Wolters Kluwer)
• Pyridostigmine Syrup Consumer Information (Wolters Kluwer)
• Pyridostigmine Tablets Consumer Information (Wolters Kluwer)
• Pyridostigmine Consumer Information (Cerner Multum)
• Pyridostigmine Bromide AHFS DI Monographs (ASHP)